Literature DB >> 8506956

Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse.

M Takemura1, S Nakamura, I Akiguchi, M Ueno, N Oka, S Ishikawa, A Shimada, J Kimura, T Takeda.   

Abstract

The immunohistochemical localization of amyloid beta/A4 protein in the senescence-accelerated mouse brain was studied using six different antisera against human amyloid precursor protein peptides. beta/A4 proteinlike immunoreactivity was observed in the form of granular structures (beta-LIGS) in various regions, including the medial septum, cerebral cortex, hippocampus, cerebellum, and some cranial nerve roots. beta-LIGS were 1.5 to 2.5 mu in diameter and irregularly shaped. They increased significantly in number with aging, predominantly in animals with a phenotype of age-related deterioration of memory and learning abilities. Congo red and thioflavine S did not stain the granules. On immunoblots, the main immunoreactive bands were observed at 14 to 18 kd. The staining intensities of these bands also increased with advancing age. We consider that beta-LIGS are not only a new morphological manifestation of senescence in mice, but also a pertinent clue in understanding the mechanisms of amyloid deposition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506956      PMCID: PMC1886996     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

2.  The comparative immunoreactivities of brain amyloids in Alzheimer's disease and scrapie.

Authors:  S A Bobin; J R Currie; P A Merz; D L Miller; J Styles; W A Walker; G Y Wen; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.

Authors:  F Coria; E M Castaño; B Frangione
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

4.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

5.  Complementary DNA for the mouse homolog of the human amyloid beta protein precursor.

Authors:  T Yamada; H Sasaki; H Furuya; T Miyata; I Goto; Y Sakaki
Journal:  Biochem Biophys Res Commun       Date:  1987-12-16       Impact factor: 3.575

6.  Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

Authors:  D A Kirschner; H Inouye; L K Duffy; A Sinclair; M Lind; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein.

Authors:  E M Castaño; J Ghiso; F Prelli; P D Gorevic; A Migheli; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

8.  A molecular-pathologic approach to murine senile amyloidosis. Serum precursor-apolipoprotein A-II variant (Pro5----Gln) presents only in the senile amyloidosis-prone SAM-P/1 and SAM-P/2 mice.

Authors:  T Yonezu; S Tsunasawa; K Higuchi; K Kogishi; H Naiki; K Hanada; F Sakiyama; T Takeda
Journal:  Lab Invest       Date:  1987-07       Impact factor: 5.662

9.  Periodic acid-Schiff (PAS)-positive, granular structures increase in the brain of senescence accelerated mouse (SAM).

Authors:  H Akiyama; M Kameyama; I Akiguchi; H Sugiyama; T Kawamata; H Fukuyama; H Kimura; M Matsushita; T Takeda
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits.

Authors:  C R Abraham; D J Selkoe; H Potter; D L Price; L C Cork
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

View more
  17 in total

1.  Early postnatal sound exposure induces lasting neuronal changes in the inferior colliculus of senescence accelerated mice (SAMP8): a morphometric study on GABAergic neurons and NMDA expression.

Authors:  Dietrich Ernst Lorke; Lai Yung Wong; Helen W L Lai; Paul W F Poon; Aiqun Zhang; Wood Yee Chan; David Tai Wai Yew
Journal:  Cell Mol Neurobiol       Date:  2003-04       Impact factor: 5.046

Review 2.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence.

Authors:  Koji Tomobe; Yasuyuki Nomura
Journal:  Neurochem Res       Date:  2009-02-27       Impact factor: 3.996

Review 4.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

5.  High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.

Authors:  K Fukuchi; L Ho; S G Younkin; D D Kunkel; C E Ogburn; R C LeBoeuf; C E Furlong; S S Deeb; D Nochlin; J Wegiel; H M Wisniewski; G M Martin
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

6.  Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency.

Authors:  N Y Calingasan; S E Gandy; H Baker; K F Sheu; J D Smith; B T Lamb; J D Gearhart; J D Buxbaum; C Harper; D J Selkoe; D L Price; S S Sisodia; G E Gibson
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

7.  Presence of a neo-epitope and absence of amyloid beta and tau protein in degenerative hippocampal granules of aged mice.

Authors:  Gemma Manich; Jaume del Valle; Itsaso Cabezón; Antoni Camins; Mercè Pallàs; Carme Pelegrí; Jordi Vilaplana
Journal:  Age (Dordr)       Date:  2013-07-19

Review 8.  The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model.

Authors:  Yoichi Chiba; Atsuyoshi Shimada; Naoko Kumagai; Keisuke Yoshikawa; Sanae Ishii; Ayako Furukawa; Shiro Takei; Masaaki Sakura; Noriko Kawamura; Masanori Hosokawa
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

9.  Cognitive-enhancing effects of hydrolysate of polygalasaponin in SAMP8 mice.

Authors:  Pan Xu; Shu-Ping Xu; Ke-Zhu Wang; Cong Lu; Hong-Xia Zhang; Rui-le Pan; Chang Qi; Yan-Yan Yang; Ying-Hui Li; Xin-Min Liu
Journal:  J Zhejiang Univ Sci B       Date:  2016-07       Impact factor: 3.066

10.  Monoamine oxidase-B-positive granular structures in the hippocampus of aged senescence-accelerated mouse (SAMP8).

Authors:  S Nakamura; I Akiguchi; N Seriu; K Ohnishi; M Takemura; M Ueno; H Tomimoto; T Kawamata; J Kimura; M Hosokawa
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.